Literature DB >> 10195775

Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection.

G A Myers1, T H Ermak, K Georgakopoulos, T Tibbitts, J Ingrassia, H Gray, H Kleanthous, C K Lee, T P Monath.   

Abstract

Recombinant Helicobacter pylori urease (rUre) has been shown to confer protection against challenge with Helicobacter felis in mice. The purpose of the present study was to examine duration of the immune response and long-term protective efficacy of immunization with rUre. Swiss Webster mice were orally immunized four times at weekly intervals with 100 microg rUre plus 5 microg heat-labile enterotoxin of Escherichia coli (LT) adjuvant, or with LT only. At 4, 10, 20 or 40 weeks post immunization, 25 rUre-immunized mice and control mice were challenged with H. felis and sacrificed at 2 or 10 weeks post-challenge. H. felis infection was assessed by gastric urease assay and by histology. Anti-H. pylori urease specific antibody levels were measured in serum and saliva both pre- and post-challenge. Over the 40 week time period, the infection rates in rUre-immunized mice were significantly lower than those in controls (p < 0.05) as assessed by gastric urease activity. Protection ranged from 79 100% at 2 weeks post-challenge and 63-78% at 10 weeks post-challenge. Gastric bacterial density in rUre-immunized mice was significantly lower than that of controls (p < 0.03) as determined by histologic assessment. Anti-urease antibody levels remained elevated in the serum and mucosal compartments at 39 weeks following immunization. This study shows that immunization with rUre plus LT results in long-lasting protective immunity against challenge with H. felis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10195775     DOI: 10.1016/s0264-410x(98)00387-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Expression, purification and immuno-characteristics of recombination UreB protein of H.pylori.

Authors:  C Wu; Q M Zou; H Guo; X P Yuan; W J Zhang; D S Lu; X H Mao
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  Systemic immune responses to oral administration of recombinant attenuated Salmonella typhimurium expressing Helicobacter pylori urease in mice.

Authors:  Xiao-Feng Liu; Jia-Lu Hu; Qi-Zheng Quan; Zi-Qin Sun; Yao-Jun Wang; Feng Qi
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

Review 3.  Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases.

Authors:  J V Solnick; D B Schauer
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

4.  CagY Is an Immune-Sensitive Regulator of the Helicobacter pylori Type IV Secretion System.

Authors:  Roberto M Barrozo; Lori M Hansen; Anna M Lam; Emma C Skoog; Miriam E Martin; Lucy P Cai; Yong Lin; Andreas Latoscha; Sebastian Suerbaum; Don R Canfield; Jay V Solnick
Journal:  Gastroenterology       Date:  2016-08-26       Impact factor: 22.682

5.  Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations.

Authors:  Michael Vajdy; Manmohan Singh; Mildred Ugozzoli; Maylene Briones; Elawati Soenawan; Lina Cuadra; Jina Kazzaz; Paolo Ruggiero; Samuele Peppoloni; Francesco Norelli; Giuseppe del Giudice; Derek O'Hagan
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

6.  Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.

Authors:  Patricia Londoño-Arcila; Donna Freeman; Harry Kleanthous; Aisling M O'Dowd; Susan Lewis; Arthur K Turner; Emma L Rees; Timothy J Tibbitts; Judith Greenwood; Thomas P Monath; Michael J Darsley
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

7.  Possible correlates of long-term protection against Helicobacter pylori following systemic or combinations of mucosal and systemic immunizations.

Authors:  Jennifer M Taylor; Melanie E Ziman; Julie Fong; Jay V Solnick; Michael Vajdy
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

8.  Immunization with a Synthetic Helicobacter pylori Peptide Induces Secretory IgA Antibodies and Protects Mice against Infection.

Authors:  David Espinosa-Ramos; Diana Caballero-Hernández; Ricardo Gomez-Flores; Armando Trejo-Chávez; Luis Jerónimo Pérez-Limón; Myriam Angélica de la Garza-Ramos; Reyes Tamez-Guerra; Patricia Tamez-Guerra; Cristina Rodriguez-Padilla
Journal:  Can J Infect Dis Med Microbiol       Date:  2019-04-01       Impact factor: 2.471

9.  Silk fibroin hydrogel as mucosal vaccine carrier: induction of gastric CD4+TRM cells mediated by inflammatory response induces optimal immune protection against Helicobacter felis.

Authors:  Chupeng Hu; Wei Liu; Ningyin Xu; An Huang; Zhenxing Zhang; Menghui Fan; Guojing Ruan; Yue Wang; Tao Xi; Yingying Xing
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.